Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey T Gibney

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic MelanomaGeoffrey T Gibney, Michael B Atkins
Clinical Advances in Hematology & Oncology : H&O|September 10, 2015
Immunotherapy or molecularly targeted therapy: what is the best initial treatment for stage IV BRAF-mutant melanoma?Geoffrey T Gibney, Michael B Atkins
Expert Opinion on Drug Metabolism & Toxicology|April 30, 2013
Clinical development of dabrafenib in BRAF mutant melanoma and other malignanciesGeoffrey T Gibney, Jonathan S Zager
The Surgical Clinics of North America|September 24, 2014
Indications and options for systemic therapy in melanomaVernon K Sondak, Geoffrey T Gibney
Hematology/Oncology Clinics of North America|June 2, 2014
Surgical management of melanomaVernon K Sondak, Geoffrey T Gibney
Cancer Discovery|March 12, 2013
An unholy alliance: cooperation between BRAF and NF1 in melanoma development and BRAF inhibitor resistanceGeoffrey T Gibney, Keiran S M Smalley
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Targeted Therapies in Combination With Immune Therapies for the Treatment of Metastatic MelanomaShelly A Christiansen, Shaheer Khan, Geoffrey T Gibney
The Lancet. Oncology|December 8, 2016
Predictive biomarkers for checkpoint inhibitor-based immunotherapyGeoffrey T Gibney, Louis M Weiner, Michael B Atkins
BMC Medicine|February 7, 2016
Advances in immunotherapy for melanomaJason M Redman, Geoffrey T Gibney, Michael B Atkins
Brain Research|May 4, 2004
Effect of protein kinases on lactate dehydrogenase activity in cortical neurons during hypoxiaSoon-Sun Hong, Geoffrey T Gibney, Manny Esquilin, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic MelanomaGeoffrey T Gibney, Michael B Atkins
Clinical Advances in Hematology & Oncology : H&O|September 10, 2015
Immunotherapy or molecularly targeted therapy: what is the best initial treatment for stage IV BRAF-mutant melanoma?Geoffrey T Gibney, Michael B Atkins
Expert Opinion on Drug Metabolism & Toxicology|April 30, 2013
Clinical development of dabrafenib in BRAF mutant melanoma and other malignanciesGeoffrey T Gibney, Jonathan S Zager
The Surgical Clinics of North America|September 24, 2014
Indications and options for systemic therapy in melanomaVernon K Sondak, Geoffrey T Gibney
Hematology/Oncology Clinics of North America|June 2, 2014
Surgical management of melanomaVernon K Sondak, Geoffrey T Gibney
Cancer Discovery|March 12, 2013
An unholy alliance: cooperation between BRAF and NF1 in melanoma development and BRAF inhibitor resistanceGeoffrey T Gibney, Keiran S M Smalley
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Targeted Therapies in Combination With Immune Therapies for the Treatment of Metastatic MelanomaShelly A Christiansen, Shaheer Khan, Geoffrey T Gibney
The Lancet. Oncology|December 8, 2016
Predictive biomarkers for checkpoint inhibitor-based immunotherapyGeoffrey T Gibney, Louis M Weiner, Michael B Atkins
BMC Medicine|February 7, 2016
Advances in immunotherapy for melanomaJason M Redman, Geoffrey T Gibney, Michael B Atkins
Brain Research|May 4, 2004
Effect of protein kinases on lactate dehydrogenase activity in cortical neurons during hypoxiaSoon-Sun Hong, Geoffrey T Gibney, Manny Esquilin, et al.
Pageof 6